Cencora (COR) Cash & Equivalents (2009 - 2026)

Cencora (COR) reported Cash & Equivalents of $2.2 billion for Q1 2026, up 10.03% on a YoY basis from $2.0 billion in Q1 2025, and up 24.15% quarter-over-quarter from $1.8 billion in Q4 2025.

Cencora (COR) Cash & Equivalents (2009 - 2026) Analysis & Trends

Cencora has reported Cash & Equivalents for 18 years, with the latest figure at $2.2 billion in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents rose 10.03% year-over-year to $2.2 billion; the trailing twelve-month figure through Mar 2026 stood at $2.2 billion (up 10.03% YoY), and the FY2025 full-year result was $4.4 billion, up 39.06% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $2.2 billion, up from $1.8 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $4.4 billion in Q3 2025, with the low at $1.4 billion in Q2 2023.
  • Historically, Cash & Equivalents has averaged $2.6 billion across 5 years, with a median of $2.6 billion in 2023.
  • Annual changes were most pronounced in 2022 — Cash & Equivalents sank 55.42% — and 2024, when it surged 137.97%.
  • Cencora's Cash & Equivalents stood at $1.7 billion in 2022, then soared by 69.74% to $2.9 billion in 2023, then climbed by 12.25% to $3.2 billion in 2024, then tumbled by 45.63% to $1.8 billion in 2025, then rose by 24.15% to $2.2 billion in 2026.
  • The last three Cash & Equivalents figures came in at $2.2 billion (Q1 2026), $1.8 billion (Q4 2025), and $4.4 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn - 176.23 Mn
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn 3.98 Bn
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn 2.18 Bn
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn 3.94 Bn
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn 138.00 Mn
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn 336.88 Mn
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn 15.00 Mn
8 111 107.47 Mn 25.61 Mn 23.58 Mn 72.04 Mn
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn 514,702.00
10 Cellyan Biotechnology 5.69 -2.48 Mn - 190,912.00

Historic Data

Download Data
DateValue
Mar 31, 2026 2.18 Bn
Dec 31, 2025 1.75 Bn
Sep 30, 2025 4.36 Bn
Jun 30, 2025 2.23 Bn
Mar 31, 2025 1.98 Bn
Dec 31, 2024 3.22 Bn
Sep 30, 2024 3.13 Bn
Jun 30, 2024 3.31 Bn
Mar 31, 2024 2.07 Bn
Dec 31, 2023 2.87 Bn
Sep 30, 2023 2.59 Bn
Jun 30, 2023 1.39 Bn
Mar 31, 2023 1.54 Bn
Dec 31, 2022 1.69 Bn
Sep 30, 2022 3.39 Bn
Jun 30, 2022 3.03 Bn
Mar 31, 2022 2.96 Bn
Dec 31, 2021 3.17 Bn
Sep 30, 2021 2.55 Bn
Jun 30, 2021 2.55 Bn